HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yourong Duan Selected Research

1,2- distearoyl- sn- glycero- 3- phosphoethanolamine- N- methoxy- poly(ethylene glycol 2000)

5/2021The targetable nanoparticle BAF312@cRGD-CaP-NP represses tumor growth and angiogenesis by downregulating the S1PR1/P-STAT3/VEGFA axis in triple-negative breast cancer.
1/2020Nanoparticle BAF312@CaP-NP Overcomes Sphingosine-1-Phosphate Receptor-1-Mediated Chemoresistance Through Inhibiting S1PR1/P-STAT3 Axis in Ovarian Carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yourong Duan Research Topics

Disease

53Neoplasms (Cancer)
02/2022 - 03/2008
10Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 01/2014
7Breast Neoplasms (Breast Cancer)
01/2022 - 02/2010
7Triple Negative Breast Neoplasms
01/2022 - 02/2019
7Prostatic Neoplasms (Prostate Cancer)
01/2022 - 04/2015
6Hepatocellular Carcinoma (Hepatoma)
10/2019 - 02/2010
5Neoplasm Metastasis (Metastasis)
03/2021 - 02/2019
4Carcinoma (Carcinomatosis)
10/2021 - 06/2012
3Stomach Neoplasms (Stomach Cancer)
10/2021 - 06/2012
3Hemolysis
03/2015 - 02/2014
2Hypoxia (Hypoxemia)
02/2022 - 07/2021
2Atherosclerosis
06/2020 - 04/2017
2Colonic Neoplasms (Colon Cancer)
02/2019 - 01/2012
2Lung Neoplasms (Lung Cancer)
10/2016 - 10/2009
2Glioblastoma (Glioblastoma Multiforme)
04/2016 - 12/2015
1Disease Progression
01/2022
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2022

Drug/Important Bio-Agent (IBA)

14Pharmaceutical PreparationsIBA
02/2022 - 11/2008
10methoxypolyethyleneglycol- poly(lactic- co- glycolic acid)IBA
02/2019 - 06/2012
8Paclitaxel (Taxol)FDA LinkGeneric
03/2021 - 06/2013
7Small Interfering RNA (siRNA)IBA
10/2021 - 06/2012
6Proteins (Proteins, Gene)FDA Link
01/2022 - 02/2014
6Contrast MediaIBA
01/2022 - 01/2019
6Peptides (Polypeptides)IBA
01/2022 - 06/2012
6monomethoxypolyethylene glycol (MPEG)IBA
06/2020 - 01/2012
5Cisplatin (Platino)FDA LinkGeneric
01/2022 - 05/2013
5Therapeutic UsesIBA
01/2021 - 12/2015
5calcium phosphateIBA
06/2020 - 01/2013
4PlatinumIBA
01/2022 - 01/2019
4LigandsIBA
01/2022 - 01/2021
4Epidermal Growth Factor (EGF)IBA
10/2021 - 05/2013
4triptolideIBA
03/2021 - 11/2017
4Doxorubicin (Adriamycin)FDA LinkGeneric
06/2020 - 06/2012
4monomethoxy (polyethylene glycol)- poly(lactide- co- glycolide)- poly(lysine)IBA
10/2016 - 06/2012
3Dexamethasone (Maxidex)FDA LinkGeneric
02/2022 - 04/2017
3Liposomes (Liposome)IBA
01/2022 - 07/2013
31,2-distearoylphosphatidylethanolamine (DSPE)IBA
05/2021 - 01/2020
3Phosphates (Orthophosphate)IBA
05/2021 - 10/2009
3IonsIBA
05/2021 - 11/2019
3Mitoxantrone (Novantrone)FDA LinkGeneric
12/2019 - 11/2008
3EmulsionsIBA
02/2019 - 06/2012
3PolymersIBA
01/2019 - 11/2008
3ErbB Receptors (EGF Receptor)IBA
03/2018 - 02/2010
3polyethylene glycol-poly(lactide-co-glycolide)IBA
12/2015 - 01/2014
3poly(lactide) (polylactic acid)IBA
06/2013 - 02/2010
3Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
01/2013 - 11/2008
3mPEG-PLGA-PLL-cRGDIBA
10/2012 - 01/2012
3Lysine (L-Lysine)FDA Link
01/2012 - 02/2010
21-phenyl-3,3-dimethyltriazene (PDT)IBA
02/2022 - 07/2021
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2022 - 05/2021
2SolutionsIBA
01/2022 - 11/2019
2human ERBB2 proteinIBA
07/2021 - 01/2013
2Ethylene Glycol (Monoethylene Glycol)IBA
07/2021 - 06/2013
2CalciumIBA
05/2021 - 01/2020
2siponimodIBA
05/2021 - 01/2020
21,2- distearoyl- sn- glycero- 3- phosphoethanolamine- N- methoxy- poly(ethylene glycol 2000)IBA
05/2021 - 01/2020
2Glutathione (Reduced Glutathione)IBA
02/2021 - 01/2019
2AntigensIBA
12/2020 - 04/2015
2HydrogelsIBA
06/2020 - 11/2016
2DNA (Deoxyribonucleic Acid)IBA
10/2019 - 10/2016
2NanogelsIBA
10/2019 - 07/2017
2bufalinIBA
02/2019 - 01/2012
2LipidsIBA
01/2019 - 07/2013
2MicroRNAs (MicroRNA)IBA
09/2018 - 03/2018
2Poloxamer (Poloxamer 407)IBA
11/2016 - 01/2013
2Temozolomide (Temodar)FDA LinkGeneric
04/2016 - 12/2015
2Fluorouracil (Carac)FDA LinkGeneric
07/2014 - 06/2012
2ChitosanIBA
07/2013 - 01/2013
2Glycine (Aminoacetic Acid)FDA LinkGeneric
06/2012 - 12/2011
2Arginine (L-Arginine)FDA Link
06/2012 - 12/2011
2Drug CarriersIBA
01/2012 - 03/2008
1hypericinIBA
02/2022
1Photosensitizing Agents (Photosensitizers)IBA
02/2022
1MicellesIBA
02/2022
1Oxygen (Dioxygen)IBA
02/2022
1Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
01/2022
1TOR Serine-Threonine KinasesIBA
01/2022
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
01/2022
1Chloroquine (Aralen)FDA LinkGeneric
01/2022
1Lactic Acid (Lactate)FDA LinkGeneric
01/2022
1AntioxidantsIBA
01/2022
1CXCR4 Receptors (CXCR4 Receptor)IBA
10/2021
1perflexane (perfluorohexane)FDA Link
07/2021
1B7-H1 AntigenIBA
07/2021
1Metformin (Glucophage)FDA LinkGeneric
07/2021
1phytochlorinIBA
07/2021
1Progesterone Receptors (Progesterone Receptor)IBA
07/2021
1Estrogen ReceptorsIBA
07/2021
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
05/2021
1arginyl-glycyl-aspartic acidIBA
05/2021
1APTIBA
03/2021
1DisulfidesIBA
02/2021

Therapy/Procedure

23Therapeutics
10/2021 - 03/2008
17Drug Therapy (Chemotherapy)
01/2022 - 02/2010
5Microbubbles
01/2021 - 12/2015
4Precision Medicine
02/2022 - 01/2019
3Intravenous Injections
10/2016 - 07/2013
3Lasers (Laser)
06/2014 - 02/2010
2Photochemotherapy (Photodynamic Therapy)
02/2022 - 07/2021
2Nanospheres
02/2019 - 03/2015